Download PDF
Am J Perinatol 2024; 41(S 01): e386-e393
DOI: 10.1055/s-0042-1755554
Original Article

Protective Effects of Lactobacillus reuteri on Intestinal Barrier Function in a Mouse Model of Neonatal Necrotizing Enterocolitis

Zhuoli Lai
1   Department of Pediatrics, Yongchuan Hospital Affiliated to Chongqing Medical University, Chongqing, China
2   Department of Pediatrics, Children's Hospital of Yongchuan District, Chongqing, China
,
Fang Gong
1   Department of Pediatrics, Yongchuan Hospital Affiliated to Chongqing Medical University, Chongqing, China
› Author Affiliations Funding This study was supported by a grant from the Chongqing Education Commission, project no.: KJQN201900420.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective The intestinal mucosal and immune barriers play considerable roles in the pathogenesis of necrotizing enterocolitis (NEC). The present research was designed to assess the protective effects of Lactobacillus reuteri (LR) DSM 17938 (LR 17938) on the intestinal barriers and its beneficial effects on inflammation in a neonatal mouse model of NEC.

Study Design Overall, 7-day-old 75 C57BL/6 neonatal mice were separated into three groups (n = 25) as follows: (1) control, (2) NEC, and (3) NEC + LR17938 (LR group). NEC mice were administered a hypertonic feeding formula and subjected to asphyxia and hypothermia. Hematoxylin and eosin (HE) staining and pathological scores were used to assess the pathological changes in the intestine. Oxidative stress was evaluated based on the levels of superoxide dismutase (SOD) and malondialdehyde (MDA). Tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels were detected to assess inflammation. Gut permeability levels, bacterial translocation, and the levels of secretory idioglobulin A (sIgA), β-defensin, and tight junction (TJ) proteins were detected to evaluate gut mucosal and immune barrier function, and gut microbial diversity was detected to assess the composition of the gut flora.

Results LR 17938 administration decreased the NEC-induced increase in intestinal scores, mortality rate, gut damage, the MDA level, and TNF-α and IL-1β expressions. Besides, LR 17938 improved the survival rate of NEC mice. Moreover, LR 17938 administration improved gut permeability levels, SOD activity and the bacterial translocation, ameliorated the expression of TJ proteins, and improved the gut microbiota compared with those of NEC mice.

Conclusion LR 17938 reduced intestinal inflammation and played a protective role in a neonatal animal model of NEC, possibly by regulating oxidative stress and exerting a protective effect on the gut mucosal and immune barriers.

Key Points

  • Our research indicated a protective effect of LR 17938 on gut barrier function in NEC mice.

  • LR 17938may affect the diversity of gut flora, which are known to target beneficial bacteria.

  • LR 17938 protected gut barrier function in the NEC pups by improving gut permeability.

Keywords

neonatal necrotizing enterocolitis - Lactobacillus reuteri DSM 17938 - oxidative damage - intestinal barrier - inflammation

Ethical Approval

The study protocol (CQMU20210813) was approved by the Experimental Animal Ethics Committee of Chongqing Medical University.




Publication History

Received: 15 April 2022

Accepted: 20 June 2022

Article published online:
11 November 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Frost BL, Modi BP, Jaksic T, Caplan MS. New medical and surgical insights into neonatal necrotizing enterocolitis: a review. JAMA Pediatr 2017; 171 (01) 83-88
    CrossrefPubMedSearch in Google Scholar
  • 2 Hackam D, Caplan M. Necrotizing enterocolitis: pathophysiology from a historical context. Semin Pediatr Surg 2018; 27 (01) 11-18
    CrossrefPubMedSearch in Google Scholar
  • 3 Zhao X, Zhou J, Liang W. et al. Probiotics mixture reinforces barrier function to ameliorate necrotizing enterocolitis by regulating PXR-JNK pathway. Cell Biosci 2021; 11 (01) 20
    CrossrefPubMedSearch in Google Scholar
  • 4 Bein A, Zilbershtein A, Golosovsky M, Davidov D, Schwartz B. LPS induces hyper-permeability of intestinal epithelial cells. J Cell Physiol 2017; 232 (02) 381-390
    CrossrefPubMedSearch in Google Scholar
  • 5 Halpern MD, Denning PW. The role of intestinal epithelial barrier function in the development of NEC. Tissue Barriers 2015; 3 (1,2): e1000707
    CrossrefPubMedSearch in Google Scholar
  • 6 van Best N, Trepels-Kottek S, Savelkoul P, Orlikowsky T, Hornef MW, Penders J. Influence of probiotic supplementation on the developing microbiota in human preterm neonates. Gut Microbes 2020; 12 (01) 1-16
    CrossrefPubMedSearch in Google Scholar
  • 7 Underwood MA, Umberger E, Patel RM. Safety and efficacy of probiotic administration to preterm infants: ten common questions. Pediatr Res 2020; 88 (suppl 1): 48-55
    CrossrefPubMedSearch in Google Scholar
  • 8 Lu P, Yamaguchi Y, Fulton WB. et al. Maternal aryl hydrocarbon receptor activation protects newborns against necrotizing enterocolitis. Nat Commun 2021; 12 (01) 1042
    CrossrefPubMedSearch in Google Scholar
  • 9 Liu Y, Tran DQ, Fatheree NY, Marc Rhoads J. Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2014; 307 (02) G177-G186
    CrossrefPubMedSearch in Google Scholar
  • 10 Bein A, Eventov-Friedman S, Arbell D, Schwartz B. Intestinal tight junctions are severely altered in NEC preterm neonates. Pediatr Neonatol 2018; 59 (05) 464-473
    CrossrefPubMedSearch in Google Scholar
  • 11 Yin Y, Wang J, Zhao X. et al. Overexpressed FOXO3 improves inflammatory status in mice by affecting NLRP3-mediated cell coronation in necrotizing colitis mice. Biomed Pharmacother 2020; 125: 109867
    CrossrefPubMedSearch in Google Scholar
  • 12 Cakir U, Tayman C, Serkant U. et al. Ginger (Zingiber officinale Roscoe) for the treatment and prevention of necrotizing enterocolitis. J Ethnopharmacol 2018; 225: 297-308
    CrossrefPubMedSearch in Google Scholar
  • 13 Thänert R, Keen EC, Dantas G, Warner BB, Tarr PI. Necrotizing Enterocolitis and the Microbiome: Current Status and Future Directions. J Infect Dis 2021; 223 (12, suppl 2): S257-S263
    CrossrefPubMedSearch in Google Scholar
  • 14 Senger S, Ingano L, Freire R. et al. Human fetal-derived enterospheres provide insights on intestinal development and a novel model to study necrotizing enterocolitis (NEC). Cell Mol Gastroenterol Hepatol 2018; 5 (04) 549-568
    CrossrefPubMedSearch in Google Scholar
  • 15 Grothaus JS, Ares G, Yuan C, Wood DR, Hunter CJ. Rho kinase inhibition maintains intestinal and vascular barrier function by upregulation of occludin in experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2018; 315 (04) G514-G528
    CrossrefPubMedSearch in Google Scholar
  • 16 Al-Hadidi A, Navarro J, Goodman SD, Bailey MT, Besner GE. Lactobacillus reuteri in its biofilm state improves protection from experimental necrotizing enterocolitis. Nutrients 2021; 13 (03) 13
    CrossrefPubMedSearch in Google Scholar
  • 17 Hoang TK, He B, Wang T, Tran DQ, Rhoads JM, Liu Y. Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2. Am J Physiol Gastrointest Liver Physiol 2018; 315 (02) G231-G240
    CrossrefPubMedSearch in Google Scholar
  • 18 Zeisel MB, Dhawan P, Baumert TF. Tight junction proteins in gastrointestinal and liver disease. Gut 2019; 68 (03) 547-561
    CrossrefPubMedSearch in Google Scholar
  • 19 Moore SA, Nighot P, Reyes C. et al. Intestinal barrier dysfunction in human necrotizing enterocolitis. J Pediatr Surg 2016; 51 (12) 1907-1913
    CrossrefPubMedSearch in Google Scholar
  • 20 Aceti A, Beghetti I, Martini S, Faldella G, Corvaglia L. Oxidative stress and necrotizing enterocolitis: pathogenetic mechanisms, opportunities for intervention, and role of human milk. Oxid Med Cell Longev 2018; 2018: 7397659
    CrossrefPubMedSearch in Google Scholar
  • 21 Parpia H, El-Sawalhy E, Khadra M. et al. Immune thrombocytopenic pupura after COVID-19 vaccine, a case report. Mediterr J Hematol Infect Dis 2021; 13 (01) e2021047
    CrossrefPubMedSearch in Google Scholar
  • 22 Özdemir ÖM, Ergin H, Yenisey Ç, Türk NŞ, Şimşek NG. Protective effects of clarithromycin in rats with hypoxia/reoxygenation-induced intestinal injury. J Pediatr Surg 2010; 45 (11) 2169-2174
    CrossrefPubMedSearch in Google Scholar
  • 23 Elgin TG, Kern SL, McElroy SJ. Development of the neonatal intestinal microbiome and its association with necrotizing enterocolitis. Clin Ther 2016; 38 (04) 706-715
    CrossrefPubMedSearch in Google Scholar